PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2223810-9	1990	Although chromaffin granule ghost-associated phospholipase A2 is most likely a lysosomal contaminant, its broad, biomembrane-modulated pH range may still allow it to participate in catecholamine secretion.	Catecholamines	181-194	LOC104974671	Bos taurus	45-61	
6865904-0	1983	Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.	Catecholamines	34-47	LOC104974671	Bos taurus	0-16	
6865904-2	1983	The possibility that it may be involved in exocytosis of catecholamine from primary dissociated cultures of bovine adrenal medullary cells was investigated by studying the effects on catecholamine secretion and 44Ca2+ uptake of three phospholipase A2 inhibitors: p-bromophenacyl bromide (BPB), Upjohn Compound 1002, and mepacrine.	Catecholamines	57-70	LOC104974671	Bos taurus	234-250	
6865904-10	1983	The data suggest that phospholipase A2 inhibitors block catecholamine secretion from intact chromaffin cells by blocking Ca2+ influx.	Catecholamines	56-69	LOC104974671	Bos taurus	22-38	
6847709-0	1983	Suppression by phospholipase A2 inhibitors of secretion of catecholamines from isolated adrenal medullary cells by suppression of cellular calcium uptake.	Catecholamines	59-73	LOC104974671	Bos taurus	15-31	
6847709-1	1983	The involvement of phospholipase A2 in the secretion of catecholamines and cellular uptake of 45Ca2+ was investigated in isolated bovine adrenal medullary cells.	Catecholamines	56-70	LOC104974671	Bos taurus	19-35	
6847709-3	1983	Phospholipase A2 inhibitors, such as quinacrine, chloroquine, quinine and p-bromophenacyl bromide, all inhibited the secretion of catecholamines evoked by carbamylcholine in a dose-dependent manner.	Catecholamines	130-144	LOC104974671	Bos taurus	0-16	
6847709-4	1983	These phospholipase A2 inhibitors also inhibited the cellular uptake of 45Ca2+ evoked by carbamylcholine with similar dose-response curves to those for inhibition of catecholamine secretion.	Catecholamines	166-179	LOC104974671	Bos taurus	6-22	
6847709-6	1983	Phospholipase A2 inhibitors seem to suppress the secretion of catecholamines by interfering with the linkage between acetylcholine receptors and Ca-channels by the membrane effects including the inhibition of endogenous phospholipase A2 activity of the adrenal medullary cells.	Catecholamines	62-76	LOC104974671	Bos taurus	0-16	
6847709-6	1983	Phospholipase A2 inhibitors seem to suppress the secretion of catecholamines by interfering with the linkage between acetylcholine receptors and Ca-channels by the membrane effects including the inhibition of endogenous phospholipase A2 activity of the adrenal medullary cells.	Catecholamines	62-76	LOC104974671	Bos taurus	220-236	
1335253-2	1992	In the present study, we examined the relationship between phospholipase A2 and C activation and catecholamine secretion by PGE2 in chromaffin cells.	Catecholamines	97-110	LOC104974671	Bos taurus	59-75	
1335253-3	1992	The phospholipase A2 inhibitors p-bromophenacyl bromide and mepacrine did not affect the basal and ouabain-induced release, but dose-dependently blocked PGE2-evoked phosphoinositide metabolism and the consequent catecholamine release at an IC50 value of 3 microM.	Catecholamines	212-225	LOC104974671	Bos taurus	4-20